Home Physical Sciences Crystal structure of (E)-resveratrol 3-O-β-D-xylopyranoside, C19H22O8
Article Open Access

Crystal structure of (E)-resveratrol 3-O-β-D-xylopyranoside, C19H22O8

  • Qing Tang , Huan-Yong Li , Zhong-Nan Wu , Ming Yan , Yu-Bo Zhang , Yao-Lan Li and Guo-Cai Wang ORCID logo EMAIL logo
Published/Copyright: December 10, 2020

Abstract

C19H22O8, orthorhombic, P212121 (no. 19), a = 4.63150(10) Å, b = 9.4846(3) Å, c = 39.7929(11) Å, V = 1748.02(8) Å3, Z = 4, Rgt(F) = 0.0340, wRref(F2) = 0.0892, T = 150 K.

CCDC no.: 2046776

The molecular structure is shown in the Figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Colourless block
Size:0.14 × 0.12 × 0.11 mm
Wavelength:Cu Kα radiation (1.54184 Å)
μ:0.95 mm−1
Diffractometer, scan mode:SuperNova, ω
θmax, completeness:67.4°, >99%
N(hkl)measured, N(hkl)unique, Rint:6494, 3156, 0.015
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 3118
N(param)refined:252
Programs:CrysAlisPRO [1], Olex2 [2], [3], SHELX [4]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomXYZUiso*/Ueq
C10.6661 (4)−0.10978 (18)0.77330 (4)0.0217 (4)
H1A0.5372−0.18430.77080.026*
C20.8223 (4)−0.09742 (18)0.80282 (4)0.0229 (4)
H2A0.8001−0.16400.81980.027*
C31.0108 (4)0.01379 (18)0.80707 (4)0.0191 (3)
C41.0466 (4)0.11240 (18)0.78147 (4)0.0203 (3)
H41.17410.18720.78430.024*
C50.8922 (4)0.09893 (18)0.75181 (4)0.0194 (3)
H5A0.91810.16490.73480.023*
C60.6979 (4)−0.01237 (17)0.74702 (4)0.0177 (3)
C70.5216 (4)−0.03063 (18)0.71664 (4)0.0193 (3)
H7A0.3860−0.10290.71730.023*
C80.5327 (4)0.04404 (17)0.68826 (4)0.0181 (3)
H80.66720.11660.68700.022*
C90.3462 (4)0.01939 (17)0.65882 (4)0.0167 (3)
C100.1551 (4)−0.09330 (17)0.65721 (4)0.0191 (3)
H100.1438−0.15630.67510.023*
C11−0.0181 (4)−0.11252 (16)0.62933 (4)0.0177 (3)
C12−0.0030 (4)−0.02099 (16)0.60223 (4)0.0175 (3)
H12−0.1181−0.03460.58340.021*
C130.1871 (4)0.09095 (16)0.60392 (4)0.0166 (3)
C140.3629 (4)0.11371 (16)0.63171 (4)0.0171 (3)
H140.48910.18990.63230.020*
C150.3401 (4)0.30353 (16)0.57576 (4)0.0153 (3)
H150.54370.28880.58150.018*
C160.3565 (4)0.52341 (16)0.60208 (4)0.0188 (3)
H16A0.55780.50530.60730.023*
H16B0.27510.57910.62020.023*
C170.3340 (4)0.60471 (16)0.56908 (4)0.0162 (3)
H170.13220.63070.56500.019*
C180.4434 (3)0.51418 (16)0.54018 (4)0.0145 (3)
H180.65320.50440.54230.017*
C190.3088 (4)0.36814 (16)0.54100 (4)0.0139 (3)
H190.10250.37730.53600.017*
O11.1597 (3)0.02127 (13)0.83677 (3)0.0264 (3)
H11.20990.10290.84020.040*
O2−0.2047 (3)−0.22444 (12)0.62964 (3)0.0244 (3)
H2−0.2956−0.22630.61200.037*
O30.1890 (3)0.17517 (11)0.57499 (3)0.0193 (3)
O40.2041 (3)0.39266 (12)0.59929 (3)0.0190 (3)
O50.5038 (3)0.72885 (11)0.57221 (3)0.0211 (3)
H50.44380.78900.55920.032*
O60.3804 (3)0.58255 (13)0.50906 (3)0.0193 (3)
H60.52470.58220.49710.029*
O70.4367 (3)0.27836 (12)0.51610 (3)0.0185 (3)
H70.58950.31290.50970.028*
O8−0.1187 (3)0.55432 (12)0.47231 (3)0.0205 (3)
H8A0.03720.54860.48350.031*
H8B−0.13930.47300.46370.031*

Source of material

The dry roots of Lysidice rhodostegia were purchased from Maoming, Guangdong Province, China. Dried Powder (14.0 kg) was extracted three times with 95% ethanol at room temperature. The solution was concentrated in vacuum to get a residue (1.5 kg). The crude extract was suspended in water and partitioned successively with petroleum ether, EtOAc and n-BuOH. The EtOAc extract (400.0 g) was chromatographed on a silica gel column eluted with CHCl3–CH3OH solvent system, afforded five fractions (Fr. 1–5). The title compound (systematic name: (E)-2-(3-hydroxy-5-(4-hydroxystyryl)phenoxy)tetrahydro-2H-pyran-3,4,5-triol) was obtained from Fr. 2 and crystallized in methanol.

Experimental details

A suitable crystal was selected and measured on a SuperNova, Dual, Cu at zero, AtlasS2 diffractometer. Using Olex2 [2], the structure was solved with the ShelXT [3]. Structure solution program using intrinsic phasing and the structure was refined with ShelXL [4].

Comment

The plant L. rhodostegia belongs to Leguminosae family. It is widely distributed in the south and southwest of China [5]. Previous chemical investigations of L. rhodostegia have revealed that phloroglucinol derivatives are the main chemical constituents of this plant [6], [7]. The roots of this plant were proved to possess antioxidant [6], antiarrhythmia [8], and vasodilation [7] activities.

The title compound was determined structurally as (E)-resveratrol 3-O-β-D-xylopyranoside [7], which belongs to a class of stilbene derivatives. It has the basic skeleton of a stilbene combined with a d-xylose group. The C-O bond lengths 1.369(2)–1.4346(18) Å, C-C bond lengths of phenyl 1.381(2)–1.404(2) Å , C-C bond lengths of alkenyl 1.334(2) Å and the other C-C bond lengths 1.469(2)–1.526(2) Å, which were derived from the title structure are with in normal ranges.


Corresponding author: Guo-Cai Wang, Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, Institute of Traditional Chinese Medicine and Natural Products, College of Pharmacy, Jinan University, Guangzhou 510632, P. R. China, E-mail:

Qing Tang and Huan-Yong Li contributed equally to this work.


Award Identifier / Grant number: 2017YFC1703800

Award Identifier / Grant number: 81973190

Award Identifier / Grant number: 81803376

Funding source: Guangdong Basic and Applied Basic Research Foundation

Award Identifier / Grant number: 2020B1515020033

Award Identifier / Grant number: 2018B030311020

Funding source: Guangdong Pearl River Talents Program

Award Identifier / Grant number: 2017BT01Y036

  1. Author contribution: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: The National Key R&D Program of China (No. 2017YFC1703800), National Natural Science Foundation of China (Nos. 81973190, 81803376), Guangdong Basic and Applied Basic Research Foundation (No. 2020B1515020033), Natural Science Foundation of Guangdong Province (No. 2018B030311020), and Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program (2017BT01Y036).

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Agilent Technologies. CrysAlisPRO; Agilent Technologies: Santa Clara, CA, USA, 2017.Search in Google Scholar

2. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341. https://doi.org/10.1107/s0021889808042726.Search in Google Scholar

3. Bourhis, L. J., Dolomanov, O. V., Gildea, R. J., Howard, J. A. K., Puschmann, H. The anatomy of a comprehensive constrained, restrained refinement program for the modern computing environment – Olex2 dissected. Acta Crystallogr. 2015, A71, 59–75. https://doi.org/10.1107/s2053273314022207.Search in Google Scholar

4. Sheldrick, G. M. SHELXTL Integrated space-group and crystal-structure determination. Acta Crystallogr. 2015, A71, 3–8. https://doi.org/10.1107/s2053273314026370.Search in Google Scholar PubMed PubMed Central

5. Zhengyi, W., Raven, P. H., Deyuan, H. Flora of china; Science Press: Beijing, 1988; p. 204.Search in Google Scholar

6. Wu, X. F., Li, L., Li, Y., Lv, H. N., Liu, B. Y., Hu, Y. C. Phloroglucinols with antioxidant activities isolated from Lysidice rhodostegia. Molecules 2017, 22, 855–863. https://doi.org/10.3390/molecules22060855.Search in Google Scholar PubMed PubMed Central

7. Gao, S., Feng, N., Yu, S. S., Yu, D. Q., Wang, X. L. Vasodilator constituents from the roots of Lysidice rhodostega. Planta Med. 2004, 70, 1128–1134. https://doi.org/10.1055/s-2004-835839.Search in Google Scholar PubMed

8. Wu, C., Li, Y. Y., Yi, X., Xu, Y. P., Zhang, Y. B., Wang, G. C., Li, Y. L. Three new acylphloroglucinol glucosides from the roots of Lysidice rhodostegia and their antioxidant activities. Carbohydr. Res. 2020, 492, 108012. https://doi.org/10.1016/j.carres.2020.108012.Search in Google Scholar PubMed

Received: 2020-10-28
Accepted: 2020-11-27
Published Online: 2020-12-10
Published in Print: 2021-03-26

© 2020 Qing Tang et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Frontmatter
  2. New Crystal Structures
  3. The crystal structure of 4-hydroxybenzene-1,3-diaminium dichloride, C6H10Cl2N2O
  4. The crystal structure of 3-chloropropylammonium chloride, C3H9Cl2N
  5. The crystal structure of 1-chloro-2-(dimethylamino)ethane hydrochloride, C4H11Cl2N
  6. Crystal structure of N-(2-(trifluoromethyl)phenyl)hexanamide, C13H16F3NO
  7. Redetermination of the crystal structure of para-toluidine, C7H9
  8. The crystal structure of bis(1,3-dihydroxy-2-methylpropan-2-aminium) carbonate, C9H24N2O7
  9. The crystal structure of 4-chloro-1-methylpiperidin-1-ium chloride, C6H13Cl2N
  10. Crystal structure of (Z)-3-(6-bromo-1H-indol-3-yl)-1,3-diphenylprop-2-en-1-one, C23H16BrNO
  11. The crystal structure of ethyl 2-amino-4-(3,5-difluorophenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carboxylate, C20H21F2NO4
  12. Crystal structure of 6,6'‐((1E,1'E)‐(propane‐1,3‐diylbis(azaneylylidene))bis(methaneylylidene))bis(3‐bromophenol), C34H32Br4N4O4
  13. The crystal structure of (E)-2-(2-((2-picolinoylhydrazono)methyl)phenoxy)acetic acid dihydrate, C15H17N3O6
  14. Crystal structure of (E)-4-bromo-N′-(3-chloro-2-hydroxybenzylidene)benzohydrazide, C14H10BrClN2O2
  15. Crystal structure of N,N′-bis(4-bromosalicylidene) ethylene-1,2-diaminopropan, C34H32Br4N4O4
  16. Crystal structure of 4-bromo-N′-[(3-bromo-2-hydroxyphenyl)methylidene]benzohydrazide methanol solvate, C15H14Br2N2O3
  17. The crystal structure of 1,2-bis(1H-benzo[d]imidazol-2-yl)ethane-1,2-diol — N-(2-aminophenyl)-3-(1H-benzo[d]imidazol-2-yl)-2,3-dihydroxypropanamide (1/1), C32H30N8O5
  18. The crystal structure of para-trifluoromethyl-aniline hemihydrate, C14H14F6N2O
  19. Redetermination of the crystal structure of 2-amino-2-methyl-propane-1,3-diole, C4H11NO2
  20. The crystal structure of methacholine chloride, C8H18ClNO2
  21. Crystal structure of 5,7,7-trimethyl-4,6,7,8-tetrahydrocyclopenta[g]isochromen-1(3H)-one, C15H18O2
  22. Crystal structure of poly[diammine-bis(μ4-4-hydroxypyridine-3-sulfonato-κ5N:O, O′:O′′:O′′)(μ2-pyrazinyl-κ2N:N′)tetrasilver(I)], C7H8Ag2N3O4S
  23. Crystal structure of ethyl (E)-5-(((3′,6′-bis(ethylamino)-3-oxospiro[isoindoline-1,9′-xanthen]-2-yl)imino)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxylate — ethanol (1/1), C38H45N5O5
  24. Crystal structure of 4-bromo-N′-[(3-chloro-2-hydroxyphenyl)methylidene]benzohydrazide, C14H7Br2N2O2
  25. Redetermination of the crystal structure of 3,3,3-triphenylpropanoic acid, C21H18O2 – Deposition of hydrogen atomic coordinates
  26. Structure redetermination of dextromethorphan hydrobromide monohydrate, C18H28BrNO2 – localization of hydrogen atoms
  27. Crystal structure of tris(azido-κ1N)-(N-(2-aminoethyl)-N-methyl-1,3-propanediamine-κ3N,N′,N′′)cobalt(III), C7H19CoN12
  28. Crystal structure of tetraaqua-bis(1H-indazole-6-carboxylate-κN)cadmium (II), C16H18CdN4O8
  29. Crystal structure of dichloride-bis(1-propylimidazole-κ1N)zinc(II), C12H20Cl2N4Zn
  30. Crystal structure of (E)-resveratrol 3-O-β-D-xylopyranoside, C19H22O8
  31. Crystal structure of 3,3′-(1,2-phenylene-bis(methylene))bis(1-vinyl- 1H-imidazol-3-ium) bis(hexafluoro phosphate)(V), C18H20F12N4P2
  32. Crystal structure of diaqua[bis(benzimidazol-2-yl-methyl)amine-κ3N,N′,N″]-phthalato-κ1O-nickel(II)-methanol (1/2), C26H31N5NiO8
  33. Crystal structure of 6,7-difluoro-1-methyl-3-(trifluoromethyl)quinoxalin-2(1H)-one, C10H5F5N2O
  34. Crystal structure of dichlorido-bis(1-hexyl-1H-benzotriazole-k1N)zinc(II), C24H34N6Cl2Zn
  35. The crystal structre of 2-(4-bromophenyl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine, C16H12BBrN2
  36. Crystal structure of diethyl 3,9-bis(4-fluorophenyl)-6,12-diphenyl-3,9-diazapentacyclo[6.4.0.02,7.04,11]dodecane-1,5-dicarboxylate, C40H36F2N2O4
  37. Crystal structure of (E)-7-methoxy-2-((5-methoxypyridin-3-yl)methylene)-3,4- dihydronaphthalen-1(2H)-one, C18H17NO3
  38. Crystal structure of (E)-2-chloro-6-(((1,3-dihydroxy-2-(oxidomethyl)propan-2-yl)imino)methyl)phenolate-κ3N,O,O’)manganese(IV), C22H24Cl2MnN2O8
  39. The crystal structure of α-(meta-methoxyphenoxy)-ortho-tolylic acid, C15H14O4
  40. The crystal structure of N-(2-chloroethyl)-N,N-diethylammonium chloride, C6H15Cl2N
  41. The crystal structure of tris(2,3,4,6,7,8,9,10-octahydro-1H-pyrimido[1,2-a]azepin-5-ium) trihydrodecavanadate(V), C27H54N6O28V10
  42. Crystal structure of 1,3-bis(octyl)benzimidazolium perchlorate C23H39ClN2O4
  43. Crystal structure of tetrakis[(Z)-(2-(1-(furan-2-yl)-2-methylpropylidene)-1-phenylhydrazin-1-ido-κ2N,N′)] zirconium(IV), C56H60N8O4Zr
  44. The crystal structure of 2-(naphthalen-2-yloxy)-4-phenyl-6-(prop-2-yn-1-yloxy)-1,3,5-triazine, C22H15N3O2
  45. The crystal structure of trimethylsulfonium tris(trifluoromethylsulfonyl)methanide, C7H9F9O6S4
  46. Crystal structure of 4-bromo-N′-[3,5-dichloro-2-hydroxyphenyl)methylidene]benzohydrazide methanol solvate, C15H13BrCl2N2O3
  47. The crystal structure of 4-(4-bromophenyl)-2-(3-(4-bromophenyl)-5-(4-fluorophenyl)-4,5-dihydro-1H-pyrazol-1-yl)thiazole, C24H16Br2FN3S
  48. The crystal structure of N-(adamantan-1-yl)-piperidine-1-carbothioamide, C16H26N2S
  49. The crystal structure of 1-phenyl-N-(4,5,6,7-tetrabromo-1,3-dioxoisoindolin-2-yl)-5-(thiophen-2-yl)-1H-pyrazole-3-carboxamide-dimethylformamide (1/1) C22H10Br4N4O3S
  50. The crystal structure of benzeneseleninic acid anhydride, C12H10O3Se2
  51. The crystal structure of diphenyalmine hydrochloride antimony trichloride co-crystallizate, C12H12Cl4NSb – Localization of hydrogen atoms
  52. The crystal structure of para-nitrobenzylbromide, C7H6BrNO2 – A second polymorph and correction of 3D coordinates
  53. Crystal structure of catena-poly[(5H-pyrrolo[3,2-b:4,5-b′]dipyridine-κ2N,N′)-(μ4-hexaoxidodivanadato)dizinc(II)],C10H9N3O6V2Zn
  54. Crystal structure of N,N′-(2-hydroxypropane-1,3-diyl)bis(pyridine-2-aldimine)-κ5N,N′,N′′,N′′′,O]-tris(nitrato-κ2O,O′) cerium(III), C15H16CeN7O10
  55. Synthesis and crystal structure of oktakis(dimethylsulphoxide-κ1O)gadolinium(III) [tetrabromido-μ2-bromido-μ2-sulfido-di-μ3-sulfido-μ4-sulfido-tetracopper(I)-tungsten(VI)], C16H48O8S12Br5Cu4GdW
  56. Crystal structure of {tris((1H-benzo[d]imidazol-2- yl)methyl)amine-κ4N,N′,N′′,N′′′}-(succinato-κ2O,O′)nickel(II) – methanol (1/4), C32H41N7NiO8
  57. Crystal structure of catena-poly[trans-tetraaqua(μ2-1,1′-(biphenyl-4,4′-diyl)bis(1H-imidazol)-k2N:N′)cobalt(II)] dinitrate – 1,1′-(biphenyl-4,4′-diyl)bis(1H-imidazol) – water (1/3/2), C72H68CoN18O12
  58. Crystal structure of bis(μ2-2-oxido-2-phenylacetate-κ3O:O,O′)-bis(1-isopropoxy-2-oxo-2-phenylethan-1-olato-κ2O,O′)-bis(propan-2-olato-κ1O)dititanium(IV), C44H52O14Ti2
  59. The crystal structure of 5-carboxy-2-(hydroxymethyl)-1H-imidazol-3-ium-4-carboxylate, C6H8N2O6
  60. The crystal structure of 2,6-dibromo-4-fluoroaniline, C6H4Br2FN
  61. The crystal structure of 4-chloro-N-(2-phenoxyphenyl)benzamide, C19H14ClNO2
  62. The crystal structure of 2-methyl-β-naphthothiazole, C12H9NS
Downloaded on 31.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2020-0554/html
Scroll to top button